Skip to content

Neurotrack Virtual Cognitive Health Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02969460
Enrollment
85
Registered
2016-11-21
Start date
2016-11-30
Completion date
2018-04-18
Last updated
2018-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjective Cognitive Decline

Brief summary

The Neurotrack Virtual Cognitive Health Study is a 12-month long, prospective study that aims to evaluate the impact of the Neurotrack Virtual Cognitive Health Coaching Program on cognitive ability, anxiety and depression, and lifestyle behaviors for individuals who show signs of subjective cognitive decline.

Interventions

BEHAVIORALNeurotrack Virtual Cognitive Health Program

Sponsors

Neurotrack
CollaboratorUNKNOWN
Evidation Health
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Ages 60-75 * Individuals who show signs of subjective cognitive decline (assessed by scoring ≥ 1 on the Subjective Cognitive Decline \[Short Form\] Questionnaire and endorsing the Personal Worry Item on the questionnaire) * Have the ability to make and receive phone calls * Have the ability to send and receive text messages * Access to a desktop computer, video-teleconferencing and reliable internet connection * Motivated to use a daily coaching program

Exclusion criteria

* Significant history of mental illness, substance abuse, learning disability, or neurologic conditions * History of dementia * Ophthalmologic/visual problems that prevent individual from viewing a computer screen at a normal distance (e.g., legal blindness, detached retinas, occlusive cataracts) * Currently participating in a formal cognitive-training coaching program * Currently pregnant

Design outcomes

Primary

MeasureTime frameDescription
RBANS scoreweek 24Repeatable Battery for the Assessment of Neuropsychological Status total score

Secondary

MeasureTime frameDescription
PHQ-9week 24Patient-health questionnaire 9-item scale
GAD-7week 24Generalized anxiety disorder 7-item scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026